CHARLES SCHWAB INVESTMENT MANAGEMENT INC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 60 filers reported holding IMMUNE DESIGN CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$474,000
+478.0%
80,936
+28.6%
0.00%
Q4 2018$82,000
-62.4%
62,9430.0%0.00%
Q3 2018$218,000
-12.1%
62,943
+15.6%
0.00%
Q2 2018$248,000
+37.8%
54,443
-0.2%
0.00%
Q1 2018$180,000
-15.5%
54,5430.0%0.00%
Q4 2017$213,000
-39.8%
54,543
+59.7%
0.00%
Q3 2017$354,000
+122.6%
34,143
+110.2%
0.00%
Q2 2017$159,000
+43.2%
16,2430.0%0.00%
Q1 2017$111,000
+23.3%
16,2430.0%0.00%
Q4 2016$90,000
-27.4%
16,2430.0%0.00%
Q3 2016$124,000
-6.8%
16,2430.0%0.00%
Q2 2016$133,000
-37.3%
16,2430.0%0.00%
Q1 2016$212,000
-35.2%
16,2430.0%0.00%
Q4 2015$327,000
+64.3%
16,2430.0%0.00%
Q3 2015$199,000
-40.8%
16,2430.0%0.00%
Q2 2015$336,000
+32.8%
16,243
+98.1%
0.00%
Q4 2014$253,0008,2000.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q2 2016
NameSharesValueWeighting ↓
Svennilson Peter 6,642,942$8,636,0007.61%
Versant Venture Management, LLC 2,208,210$2,870,673,0001.42%
BVF INC/IL 5,185,383$6,741,0000.88%
EcoR1 Capital, LLC 5,603,191$7,284,0000.73%
Abingworth LLP 352,300$458,0000.42%
Bain Capital Public Equity Management, LLC 892,061$1,160,0000.11%
ALGERT GLOBAL LLC 92,591$120,0000.03%
GSA CAPITAL PARTNERS LLP 41,068$53,0000.01%
OXFORD ASSET MANAGEMENT LLP 136,468$177,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 27,122$35,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders